G. Chene, J. Sterne, and M. May, Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies, Lancet, vol.362, issue.9385, pp.679-686, 2003.

D. Moore, R. Hogg, K. Chan, M. Tyndall, B. Yip et al., Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response, AIDS, vol.20, issue.3, pp.371-377, 2006.
DOI : 10.1097/01.aids.0000196180.11293.9a

C. Sabin, C. Smith, and M. Youle, Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers, AIDS, vol.20, issue.1, pp.67-71, 2006.
DOI : 10.1097/01.aids.0000196178.73174.24

J. Sterne, M. Hernan, and B. Ledergerber, Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study, The Lancet, vol.366, issue.9483, pp.378-384, 2005.
DOI : 10.1016/S0140-6736(05)67022-5

E. Wood, R. Hogg, B. Yip, P. Harrigan, O. Shaughnessy et al., The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.35, issue.3, pp.261-268, 2004.
DOI : 10.1097/00126334-200403010-00006

Y. Barron, S. Cole, and R. Greenblatt, Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy, AIDS, vol.18, issue.11, pp.1579-1584, 2004.
DOI : 10.1097/01.aids.0000131359.37210.1f

J. Viard, A. Mocroft, and A. Chiesi, Influence of Age on CD4 Cell Recovery in Human Immunodeficiency Virus???Infected Patients Receiving Highly Active Antiretroviral Therapy: Evidence from the EuroSIDA Study, The Journal of Infectious Diseases, vol.183, issue.8, pp.1290-1294, 2001.
DOI : 10.1086/319678

T. Giordano, J. Wright, M. Hasan, A. White, J. Graviss et al., Do Sex and Race/Ethnicity Influence CD4 Cell Response in Patients Who Achieve Virologic Suppression during Antiretroviral Therapy?, Clinical Infectious Diseases, vol.37, issue.3, pp.433-437, 2003.
DOI : 10.1086/376638

A. Bouhnik, M. Preau, and E. Vincent, Depression and clinical progression in HIVinfected drug users treated with highly active antiretroviral therapy, Antivir Ther, vol.10, issue.1, pp.53-61, 2005.

M. Miller, C. Haley, M. Koziel, and C. Rowley, Impact of Hepatitis C Virus on Immune Restoration in HIV-Infected Patients Who Start Highly Active Antiretroviral Therapy: A Meta-analysis, Clinical Infectious Diseases, vol.41, issue.5, pp.713-720, 2005.
DOI : 10.1086/432618

G. Lucas, M. Griswold, K. Gebo, J. Keruly, R. Chaisson et al., Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral Therapy, American Journal of Epidemiology, vol.163, issue.5, pp.412-420, 2006.
DOI : 10.1093/aje/kwj059

F. Hamers, A. Downs, J. Nellen, F. Wit, D. Wolf et al., The changing face of the HIV epidemic in western Europe: what are the implications for public health policies? Lancet Virologic and Immunologic Response to Highly Active Antiretroviral Therapy in Indigenous and Nonindigenous HIV-1-Infected Patients in The Netherlands, J Acquir Immune Defic Syndr, vol.36436, issue.134, pp.83-94943, 2004.

C. Sabine, AIDS events among individuals initiating HAART: do some patients experience a greater benefit from HAART than others?, AIDS, vol.19, issue.17, pp.1995-2000, 2005.
DOI : 10.1097/01.aids.0000189858.59559.d2

F. Bourdillon and J. Nadal, Les problèmes de santé et les besoins des personnes atteintes d'infection à VIH : enquête hospitalière multicentrique: Ministère de l'Emploi et de la Solidarité, Direction des Hôpitaux -Mission Sida, 1996.

P. Peretti-watel, B. Riandey, and R. Dray-spira, Surveying the HIV-Positive Population in France. The ANRS-EN12-VESPA, Survey. Population, vol.60, issue.4, pp.525-550, 2003.

J. Deville and C. Särndal, Calibration estimation in survey sampling, J Am Stat Assoc, vol.87, issue.418, pp.375-382, 1992.

F. Lert, Y. Obadia, A. The, and . Team, Living with HIV/AIDS in France. Population and societies [French]. 19. Zigmond AS, Snaith RP. The hospital anxiety and depression scale, Acta Psychiatr Scand, vol.67, issue.4066, pp.361-370, 1983.
URL : https://hal.archives-ouvertes.fr/hal-00513459

M. Carrieri, F. Raffi, and C. Lewden, Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study, Antivir Ther, vol.8, issue.6, pp.585-594, 2003.

P. Peretti-watel, B. Spire, and M. Schiltz, Vulnerability, unsafe sex and non-adherence to HAART: Evidence from a large sample of French HIV/AIDS outpatients, Social Science & Medicine, vol.62, issue.10, pp.2420-2433, 2006.
DOI : 10.1016/j.socscimed.2005.10.020
URL : https://hal.archives-ouvertes.fr/inserm-00086758

M. Goldberg, J. Chastang, and A. Leclerc, Socioeconomic, Demographic, Occupational, and Health Factors Associated with Participation in a Long-term Epidemiologic Survey: A Prospective Study of the French GAZEL Cohort and Its Target Population, American Journal of Epidemiology, vol.154, issue.4, pp.373-384, 2001.
DOI : 10.1093/aje/154.4.373

S. Jensen-fangel, L. Pedersen, and C. Pedersen, The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients al. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy, Clin Infect Dis. J Infect Dis, vol.35190, issue.1210, pp.1541-15481860, 2002.

A. Frater, D. Dunn, and A. Beardall, Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy, AIDS, vol.16, issue.8, pp.1139-1146, 2002.
DOI : 10.1097/00002030-200205240-00007

K. Anastos, M. Schneider, and S. Gange, The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women, J Acquir Immune Defic Syndr, vol.39, issue.5, pp.537-544, 2005.

P. Braitstein, M. Brinkhof, and F. Dabis, Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries, Lancet, vol.367, issue.9513, pp.817-824, 2006.

D. Jones, S. Beach, R. Forehand, M. Smith, B. Rapkin et al., Disease status in African American single mothers with HIV: the role of depressive symptoms Housing status and health care service utilization among low-income persons with HIV/AIDS, Health Psychol. J Gen Intern Med, vol.2015, issue.2910, pp.417-423731, 2000.

E. Ashton, M. Vosvick, and M. Chesney, Social Support and Maladaptive Coping as Predictors of the Change in Physical Health Symptoms among Persons Living with HIV/AIDS, AIDS Patient Care and STDs, vol.19, issue.9, pp.587-598, 2005.
DOI : 10.1089/apc.2005.19.587

G. Ironson, O. Cleirigh, C. Fletcher, and M. , Psychosocial Factors Predict CD4 and Viral Load Change in Men and Women With Human Immunodeficiency Virus in the Era of Highly Active Antiretroviral Treatment, Psychosomatic Medicine, vol.67, issue.6, pp.1013-1021, 2005.
DOI : 10.1097/01.psy.0000188569.58998.c8

S. Kalichman, S. Catz, and B. Ramachandran, Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education, J Natl Med Assoc, vol.91, issue.8, pp.439-446, 1999.

M. Wolf, T. Davis, and A. Arozullah, Relation between literacy and HIV treatment knowledge among patients on HAART regimens, AIDS Care, vol.34, issue.7, pp.863-873, 2005.
DOI : 10.1080/09540120310001595159

J. Erwin and B. Peters, Treatment issues for HIV+ Africans in London, Social Science & Medicine, vol.49, issue.11, pp.1519-1528, 1999.
DOI : 10.1016/S0277-9536(99)00220-8